Biomarcadors de diagnòstic, pronòstic i predicció de resposta a tractaments oncològics Authors Marina Rigau Mireia Olivan Marta Llauradó Eva Colás Andreas Doll Jaume Reventós i Puigjaner Abstract Better biomarkers are urgently needed to improve diagnosis, prognosis, and targeted intherapy across a wide range of diseases. Currently, scientists are moving forward to solve this problem. New developments in research help to discover many more biomarkers than ever before. However, although the number of articles that have been published in this area is increasing, only few biomarkers have been implemented in the clinical practice. This is mainly due to two reasons: biomarkers fail to meet the demands of the clinic; and false discoveries fail during the long way that represents the validation phases. The new biomarker pipeline, which currently includes new phases in the middle of the process, has significantly increased the percentage of success. In other words, the chances that the new findings are incorporated into routine clinical practice and improve the patient care are higher than before. This improvement in diagnosis, prognosis and targeted therapy, which is increasingly more specific for each patient who suffers a certain disease, brings us step by step closer to what is known as personalized medicine. Downloads Text complet (Català) Published 2014-02-27 Issue 64, 2013 : Les malalties del segle XXI / Jordi Barquinero i Jaume Reventós, editors Section Articles License The intellectual property of the articles belongs to the respective authors. At the time of submitting the articles to Treballs de la Societat Catalana de Biologia, authors accept the following terms: — Authors assign to the SCB (a subsidiary of the Institut d’Estudis Catalans) the rights of reproduction, public communication (including communication through social networks) and distribution of the articles submitted for publication to Treballs de la Societat Catalana de Biologia, in any form and medium, including digital platforms. The Publications Committee reserves the right to accept or refuse submitted articles and the right to make any editorial changes it deems appropriate. If the suggested changes are accepted by authors, they should re-submit the article with such changes. — Authors answer to the SCB for the authorship and originality of submitted articles. In other words, authors assure that submitted articles do not contain fragments of works by other authors or fragments of their own previously published works; that the content of articles is original, and that the copyright of third parties is not infringed upon. Authors accept this responsibility and undertake to hold harmless the SCB for any loss or damage resulting from non-compliance with this obligation. Furthermore, they should include a statement in articles submitted to the journal regarding their responsibility for the content of the articles. — Authors are responsible for obtaining permission for the reproduction of all graphic material included in articles, and they should moreover ensure that images, videos, etc., have been created with the consent of the individuals appearing in them, and that material belonging to third parties is clearly identified and acknowledged as such within the text. Likewise, authors should provide the respective consents and authorisations to the SCB when submitting articles. — The SCB is exempt from any liability arising from the possible infringement of intellectual property rights by authors. In all cases, it undertakes to publish corrections, clarifications, retractions and apologies, if necessary. — Unless otherwise stated in the text or in the graphic material, the contents published in the journal are subject to an Attribution - NonCommercial - NoDerivs 3.0 Spain (by-nc-nd) license from Creative Commons, the full text of which may be consulted at https://creativecommons.org/licenses/by-nc-nd/3.0/es/deed.en. Therefore, the general public is authorised to reproduce, distribute and communicate articles as long as their authorship and publishing entity are acknowledged, and no commercial use is made of them nor derivative work produced from them. — The journal is not responsible for the ideas and opinions expressed by the authors of published articles.
